Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127736241 | 12773624 | 1 | I | 201606 | 20160919 | 20160923 | 20160923 | EXP | US-ROCHE-1832772 | ROCHE | 66.07 | YR | M | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127736241 | 12773624 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DOSE WAS BASED ON WEIGHT | Y | 103705 | SOLUTION FOR INFUSION | TIW | |||||||
127736241 | 12773624 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Y | 103705 | |||||||||||
127736241 | 12773624 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | LONGER DURATION GRANULATION STIMULATING MEDICATION | D | 125031 | |||||||||
127736241 | 12773624 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | Y | 0 | ||||||||||
127736241 | 12773624 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Y | 0 | |||||||||||
127736241 | 12773624 | 6 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | Y | 0 | ||||||||||
127736241 | 12773624 | 7 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Y | 0 | |||||||||||
127736241 | 12773624 | 8 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | Y | 0 | ||||||||||
127736241 | 12773624 | 9 | SS | VINCRISTINE | VINCRISTINE | 1 | Y | 0 | |||||||||||
127736241 | 12773624 | 10 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | Y | 0 | ||||||||||
127736241 | 12773624 | 11 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Y | 0 | |||||||||||
127736241 | 12773624 | 12 | C | CLARITIN (UNITED STATES) | 2 | Unknown | 0 | 10 | MG | QD | |||||||||
127736241 | 12773624 | 13 | C | CLARITIN (UNITED STATES) | 2 | 0 | |||||||||||||
127736241 | 12773624 | 14 | C | FLONASE (UNITED STATES) | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127736241 | 12773624 | 1 | Lymphoma |
127736241 | 12773624 | 2 | Non-Hodgkin's lymphoma |
127736241 | 12773624 | 3 | Neutropenia |
127736241 | 12773624 | 4 | Lymphoma |
127736241 | 12773624 | 5 | Non-Hodgkin's lymphoma |
127736241 | 12773624 | 6 | Lymphoma |
127736241 | 12773624 | 7 | Non-Hodgkin's lymphoma |
127736241 | 12773624 | 8 | Lymphoma |
127736241 | 12773624 | 9 | Non-Hodgkin's lymphoma |
127736241 | 12773624 | 10 | Lymphoma |
127736241 | 12773624 | 11 | Non-Hodgkin's lymphoma |
127736241 | 12773624 | 12 | Bone pain |
127736241 | 12773624 | 13 | Seasonal allergy |
127736241 | 12773624 | 14 | Seasonal allergy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127736241 | 12773624 | OT |
127736241 | 12773624 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127736241 | 12773624 | Asthenia | |
127736241 | 12773624 | Bone pain | |
127736241 | 12773624 | Decreased appetite | |
127736241 | 12773624 | Drug ineffective | |
127736241 | 12773624 | Fatigue | |
127736241 | 12773624 | Neutropenia | |
127736241 | 12773624 | Oropharyngeal pain | |
127736241 | 12773624 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127736241 | 12773624 | 1 | 201603 | 20160714 | 0 | |
127736241 | 12773624 | 4 | 201603 | 0 | ||
127736241 | 12773624 | 6 | 201603 | 0 | ||
127736241 | 12773624 | 8 | 201603 | 0 | ||
127736241 | 12773624 | 10 | 201603 | 0 |